{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-031840","form_type":"8-K","ticker":"TNON","cik":"0001560293","company_name":"Tenon Medical, Inc.","filed_at":"2026-03-19T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.432846+00:00","generated_at":"2026-05-15T09:37:30.429310+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Tenon Medical Q4 revenue $1.5M (+92% YoY); full year $3.9M (+20%); FDA clearance for next-gen SI fusion system","bullets":["Q4 revenue $1.5M (+92% YoY); gross margin improved to 69% from 46%.","Full year 2025 revenue $3.9M (+20% YoY); gross margin 60%, up from 52%.","Net loss improved: Q4 loss $2.8M ($0.29/sh) vs $3.1M ($0.98/sh); full year loss $12.6M ($1.70/sh) vs $13.7M ($11.26/sh).","Received FDA 510(k) clearance for SImmetry+ SI Joint Fusion System, expanding to lateral approach.","Closed $4.3M convertible note offering in March 2026; cash $3.8M at year-end, no debt."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-031840","json":"https://secwatch.observer/filing/0001213900-26-031840.json","markdown":"https://secwatch.observer/filing/0001213900-26-031840.md","text":"https://secwatch.observer/filing/0001213900-26-031840.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1560293/000121390026031840/0001213900-26-031840-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1560293/000121390026031840/ea0282552-8k_tenon.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T09:37:30.429310+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}